CIK 0001896212 · <br>Emerging growth company
CDT Equity Inc.
Sign in to watch- Ticker
- CDT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 873272543
- Phone
- (646) 491 9132
- Business address
- 4851 TAMIAMI TRAIL NORTH, SUITE 200, NAPLES, FL, 34103
- Former names
- CONDUIT PHARMACEUTICALS INC., Murphy Canyon Acquisition Corp.
Securities
- CDT Common Stock Nasdaq
- CDTTW Warrant Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 2 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-18 | Farley Chele Chiavacci Director | Grant or award · Stock Option (Right to Buy) | +420,000 | $0.07 | $30K | 420,000 |
| 2024-12-18 | Charles Faith L. Director | Grant or award · Stock Option (Right to Buy) | +420,000 | $0.07 | $30K | 420,000 |
| 2024-12-18 | Fry Simon Jeremy Director | Grant or award · Stock Option (Right to Buy) | +420,000 | $0.07 | $30K | 420,000 |
| 2024-11-18 | Tapolczay David Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +840,000 | $0.09 | $77K | 840,000 |
| 2024-11-18 | Lewis-Hall Freda C Director | Grant or award | +437,976 | $0.09 | $40K | 437,976 |
| 2024-11-18 | Farley Chele Chiavacci Director | Grant or award | +299,238 | $0.09 | $27K | 351,510 |
| 2024-11-18 | Charles Faith L. Director | Grant or award | +75,000 | 75,000 | ||
| 2024-11-18 | Charles Faith L. Director | Grant or award | +266,594 | $0.09 | $24K | 341,594 |
| 2024-11-18 | Bligh James Interim CFO | Grant or award · Stock Option (Right to Buy) | +1,890,000 | $0.09 | $174K | 1,890,000 |
| 2024-10-07 | Nirland Ltd 10% owner | Sale | −939,009 | $0.10 | $97K | 6,092,000 |
| 2024-10-04 | Nirland Ltd 10% owner | Sale | −1,368,991 | $0.10 | $140K | 7,031,009 |
| 2024-10-03 | Nirland Ltd 10% owner | Sale | −1,500,000 | $0.10 | $156K | 8,400,000 |
| 2024-10-02 | Nirland Ltd 10% owner | Sale | −333,177 | $0.10 | $34K | 9,900,000 |
| 2024-10-01 | Nirland Ltd 10% owner | Sale | −1,250,000 | $0.11 | $141K | 10,233,177 |
| 2024-09-30 | Nirland Ltd 10% owner | Sale | −1,016,823 | $0.12 | $122K | 11,483,177 |
| 2024-07-17 | Regan Andrew Director | Sale | −1,514,100 | $0.26 | $391K | 177,627 |
| 2024-07-16 | Regan Andrew Director | Sale | −10,244,392 | $0.32 | $3.2M | 1,691,727 |
| 2024-07-15 | Regan Andrew Director | Sale | −1,005,200 | $0.25 | $248K | 11,936,119 |
| 2024-07-12 | Regan Andrew Director | Sale | −1,389,820 | $0.25 | $343K | 12,941,319 |
| 2024-07-11 | Regan Andrew Director | Sale | −582,952 | $0.30 | $173K | 14,631,139 |
Page 3 of 5 · 90 trades